131 related articles for article (PubMed ID: 8099339)
1. The use of peripheral stem cell support of high-dose chemotherapy.
Kessinger A; Armitage JO
Important Adv Oncol; 1993; ():167-75. PubMed ID: 8099339
[TBL] [Abstract][Full Text] [Related]
2. Is blood or bone marrow better?
Kessinger A
Stem Cells; 1993 Jul; 11(4):290-5. PubMed ID: 8104616
[TBL] [Abstract][Full Text] [Related]
3. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
4. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
5. The Nebraska experience.
Kessinger A
Stem Cells; 1995 Dec; 13 Suppl 3():23-7. PubMed ID: 8747985
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
Elfenbein GJ
Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
8. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
Mayer J; Korístek Z; Pospísil Z; Vásová I; Adam Z; Hájek R; Krejcí M; Král Z; Navrátil M; Vorlícek J; Bourková L; Matýsková M; Adler J; Vinklárková J; Klabusay M; Koutná I; Hoffová V; Schmitzová D; Janovská E
Cas Lek Cesk; 1999 Mar; 138(6):170-7. PubMed ID: 10510531
[TBL] [Abstract][Full Text] [Related]
9. [Introduction and prospect of peripheral blood stem cell transplantation].
Nakanishi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():24-8. PubMed ID: 8752478
[TBL] [Abstract][Full Text] [Related]
10. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
12. Is blood a better source of allogeneic hematopoietic stem cells for use after radiation accidents?
Frickhofen N; Körbling M; Fliedner TM
Bone Marrow Transplant; 1996 Feb; 17(2):131-5. PubMed ID: 8640157
[TBL] [Abstract][Full Text] [Related]
13. The whys and hows of hematopoietic progenitor and stem cell mobilization.
Kessinger A; Sharp JG
Bone Marrow Transplant; 2003 Mar; 31(5):319-29. PubMed ID: 12634722
[TBL] [Abstract][Full Text] [Related]
14. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood progenitor cell mobilization: a clinical review.
Kennedy MJ
Pharmacotherapy; 1998; 18(1 Pt 2):3S-8S. PubMed ID: 9473173
[TBL] [Abstract][Full Text] [Related]
16. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K; Margolin K; Champlin R; Forman S
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
[TBL] [Abstract][Full Text] [Related]
17. Human hematopoietic progenitor in bone marrow and peripheral blood.
Messner HA
Stem Cells; 1998; 16 Suppl 1():93-6. PubMed ID: 11012151
[TBL] [Abstract][Full Text] [Related]
18. An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma.
Duncan N; Hewetson M; Powles R; Raje N; Mehta J
Bone Marrow Transplant; 1996 Dec; 18(6):1175-8. PubMed ID: 8971391
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.
Vose JM; Armitage JO; Kessinger A
Oncology (Williston Park); 1993 Aug; 7(8):23-9; discussion 29-30, 33-4. PubMed ID: 8104456
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
Vellenga E; van Putten WL; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Jonkhoff AR; Huijgens PC; Verdonck LF; van der Lelie J; Schouten HC; Gmür J; Wijermans P; Gratwohl A; Hess U; Fey MF; Löwenberg B
Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
